Does LEUPROLIDE Cause Malignant melanoma? 53 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 53 reports of Malignant melanoma have been filed in association with LEUPROLIDE (Fensolvi). This represents 0.1% of all adverse event reports for LEUPROLIDE.
53
Reports of Malignant melanoma with LEUPROLIDE
0.1%
of all LEUPROLIDE reports
5
Deaths
7
Hospitalizations
How Dangerous Is Malignant melanoma From LEUPROLIDE?
Of the 53 reports, 5 (9.4%) resulted in death, 7 (13.2%) required hospitalization.
Is Malignant melanoma Listed in the Official Label?
Yes, Malignant melanoma is listed as a known adverse reaction in the official FDA drug label for LEUPROLIDE.
What Other Side Effects Does LEUPROLIDE Cause?
Hot flush (9,146)
Death (8,772)
Intercepted product preparation error (8,621)
Syringe issue (7,847)
Device leakage (5,861)
Wrong technique in product usage process (5,062)
Fatigue (4,805)
Injection site pain (4,678)
Prostatic specific antigen increased (2,432)
Asthenia (2,176)
What Other Drugs Cause Malignant melanoma?
SILDENAFIL (1,248)
ADALIMUMAB (795)
TADALAFIL (741)
ETANERCEPT (495)
INFLIXIMAB (478)
METHOTREXATE (475)
DABRAFENIB (402)
LENALIDOMIDE (378)
RANITIDINE (352)
RITUXIMAB (291)
Which LEUPROLIDE Alternatives Have Lower Malignant melanoma Risk?
LEUPROLIDE vs LEVALBUTEROL
LEUPROLIDE vs LEVAMISOLE
LEUPROLIDE vs LEVAQUIN
LEUPROLIDE vs LEVEMIR
LEUPROLIDE vs LEVETIRACETAM